Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Obsessive-Compulsive Disorder Therapeutics Clinical Trials 27 Prominent Drugs 28 Clinical Trial Profile Snapshots 29 Appendix 156 Abbreviations 156 Definitions 156 Research Methodology 157 Secondary Research 157 About GlobalData 158 Contact Us 158 Disclaimer 158 Source 159

List of Tables Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Region, 2016* 6 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13 Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14 Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17 Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Obsessive-Compulsive Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 List of Figures Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12 Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14 Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17 Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Obsessive-Compulsive Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 157

F. Hoffmann-La Roche Ltd. Pfizer Inc. The Lundbeck Foundation AstraZeneca Plc Allergan Plc Torrent Pharmaceuticals Limited Johnson & Johnson Novartis AG Morningside Healthcare Limited Eli Lilly and Company